Efficacy and safety of lipegfilgrastim versus pegfilgrastim: a randomized, multicenter, active-control phase 3 trial in patients with breast cancer receiving doxorubicin/docetaxel...

by Bondarenko, Igor, Gladkov, Oleg A, Elsaesser, Reiner, Buchner, Anton, Bias, Peter
Published 2013

Phase II study of axitinib with doublet chemotherapy in patients with advanced squamous non–small-cell lung cancer

by Bondarenko, Igor M, Ingrosso, Antonella, Bycott, Paul, Kim, Sinil, Cebotaru, Cristina L
Published in BMC Cancer (2015)

A Phase III Study of Balugrastim Versus Pegfilgrastim in Breast Cancer Patients Receiving Chemotherapy With Doxorubicin and Docetaxel

by Gladkov, Oleg, Moiseyenko, Vladimir, Bondarenko, Igor N., Shparyk, Yaroslav, Barash, Steve, Adar, Liat, Avisar, Noa
Published in Oncologist (2016)

Phase III, randomized, double-blind, placebo-controlled, multicenter study of lipegfilgrastim in patients with non-small cell lung cancer receiving myelosuppressive therapy

by Volovat, Constantin, Bondarenko, Igor M, Gladkov, Oleg A, Elsässer, Reiner, Buchner, Anton, Bias, Peter, Müller, Udo
Published in Springerplus (2015)

Efficacy and safety of RGB-02, a pegfilgrastim biosimilar to prevent chemotherapy-induced neutropenia: results of a randomized, double-blind phase III clinical study vs. reference...

by Kahan, Zsuzsanna, Grecea, Daniela, Smakal, Martin, Tjulandin, Sergei, Bondarenko, Igor, Perjesi, Luca, Illes, Andras, Horvat-Karajz, Karoly, Aradi, Ildiko
Published in BMC Cancer (2019)

PF-06439535 (a Bevacizumab Biosimilar) Compared with Reference Bevacizumab (Avastin(®)), Both Plus Paclitaxel and Carboplatin, as First-Line Treatment for Advanced Non-Squamous Non...

by Reinmuth, Niels, Bryl, Maciej, Bondarenko, Igor, Syrigos, Kostas, Vladimirov, Vladimir, Zereu, Manuela, Bair, Angel H., Hilton, Fiona, Liau, Katherine, Kasahara, Kazuo
Published in BioDrugs (2019)

Randomized phase II study of pemetrexed/cisplatin with or without axitinib for non-squamous non-small-cell lung cancer

by Belani, Chandra P, Yamamoto, Nobuyuki, Bondarenko, Igor M, Poltoratskiy, Artem, Novello, Silvia, Tang, Jie, Bycott, Paul, Niethammer, Andreas G, Ingrosso, Antonella, Kim, Sinil, Scagliotti, Giorgio V
Published 2014

NEPA, a fixed oral combination of netupitant and palonosetron, improves control of chemotherapy-induced nausea and vomiting (CINV) over multiple cycles of chemotherapy: results of...

by Aapro, Matti, Karthaus, Meinolf, Schwartzberg, Lee, Bondarenko, Igor, Sarosiek, Tomasz, Oprean, Cristina, Cardona-Huerta, Servando, Hansen, Vincent, Rossi, Giorgia, Rizzi, Giada, Borroni, Maria Elisa, Rugo, Hope
Published in Support Care Cancer (2016)

Five-Year Survival Rates for Treatment-Naive Patients With Advanced Melanoma Who Received Ipilimumab Plus Dacarbazine in a Phase III Trial

by Maio, Michele, Grob, Jean-Jacques, Aamdal, Steinar, Bondarenko, Igor, Robert, Caroline, Thomas, Luc, Garbe, Claus, Chiarion-Sileni, Vanna, Testori, Alessandro, Chen, Tai-Tsang, Tschaika, Marina, Wolchok, Jedd D.
Published in J Clin Oncol (2015)

Trilaciclib prior to chemotherapy and atezolizumab in patients with newly diagnosed extensive‐stage small cell lung cancer: A multicentre, randomised, double‐blind, placebo‐control...

by Daniel, Davey, Kuchava, Vladimer, Bondarenko, Igor, Ivashchuk, Oleksandr, Reddy, Sreekanth, Jaal, Jana, Kudaba, Iveta, Hart, Lowell, Matitashvili, Amiran, Pritchett, Yili, Morris, Shannon R., Sorrentino, Jessica A., Antal, Joyce M., Goldschmidt, Jerome
Published in Int J Cancer (2021)

Efficacy, Safety, and Immunogenicity of HLX02 Compared with Reference Trastuzumab in Patients with Recurrent or Metastatic HER2-Positive Breast Cancer: A Randomized Phase III Equiv...

by Xu, Binghe, Zhang, Qingyuan, Sun, Tao, Li, Wei, Teng, Yue’e, Hu, Xichun, Bondarenko, Igor, Adamchuk, Hryhoriy, Zhang, Liangming, Trukhin, Dmytro, Wang, Shusen, Zheng, Hong, Tong, Zhongsheng, Shparyk, Yaroslav, Wang, Qingyu
Published in BioDrugs (2021)

Efficacy and Safety of Bevacizumab Biosimilar FKB238 Versus Originator Bevacizumab: Results from AVANA, a Phase III Trial in Patients with Non-Squamous Non-Small-Cell Lung Cancer (...

by Syrigos, Konstantinos, Abert, Istvan, Andric, Zoran, Bondarenko, Igor N, Dvorkin, Mikhail, Galic, Kristina, Galiulin, Rinat, Kuchava, Vladimer, Sriuranpong, Virote, Trukhin, Dmytro, Zhavrid, Edvard, Fu, Dongyue, Kassalow, Laurent M, Jones, Stephanie, Bashir, Zahid
Published in BioDrugs (2021)

Final Overall Survival: Fulvestrant 500mg vs 250mg in the Randomized CONFIRM Trial

by Leo, Angelo Di, Jerusalem, Guy, Petruzelka, Lubos, Torres, Roberto, Bondarenko, Igor N., Khasanov, Rustem, Verhoeven, Didier, Pedrini, José L., Smirnova, Iya, Lichinitser, Mikhail R., Pendergrass, Kelly, Malorni, Luca, Garnett, Sally, Rukazenkov, Yuri, Martin, Miguel
Published 2013

Comparing duration of response and duration of clinical benefit between fulvestrant treatment groups in the CONFIRM trial: application of new methodology

by Garnett, Sally Anne, Martin, Miguel, Jerusalem, Guy, Petruzelka, Lubos, Torres, Roberto, Bondarenko, Igor N., Khasanov, Rustem, Verhoeven, Didier, Pedrini, José L., Smirnova, Iva, Lichinitser, Mikhail R., Pendergrass, Kelly, Lindemann, Justin P. O., Di Leo, Angelo
Published 2013

Overall survival results from the randomized phase 2 study of palbociclib in combination with letrozole versus letrozole alone for first-line treatment of ER+/HER2− advanced breast...

by Finn, Richard S., Boer, Katalin, Bondarenko, Igor, Patel, Ravindranath, Pinter, Tamas, Schmidt, Marcus, Shparyk, Yaroslav V., Thummala, Anu, Voitko, Nataliia, Bananis, Eustratios, McRoy, Lynn, Wilner, Keith, Huang, Xin, Kim, Sindy, Slamon, Dennis J., Ettl, Johannes
Published in Breast Cancer Res Treat (2020)

Efficacy of Plinabulin vs Pegfilgrastim for Prevention of Chemotherapy-Induced Neutropenia in Adults With Non–Small Cell Lung Cancer: A Phase 2 Randomized Clinical Trial

by Blayney, Douglas W., Zhang, Qingyuan, Feng, Jifeng, Zhao, Yanqiu, Bondarenko, Igor, Vynnychenko, Ihor, Kovalenko, Nadezhda, Nair, Santosh, Ibrahim, Emad, Udovista, Dmitriy Petrovich, Mohanlal, Ramon, Ogenstad, Stephan, Ette, Ene, Du, Lihua, Huang, Lan, Shi, Yuan-kai
Published in JAMA Oncol (2020)

Efficacy and safety of palbociclib in combination with letrozole as first-line treatment of ER-positive, HER2-negative, advanced breast cancer: expanded analyses of subgroups from...

by Finn, Richard S., Crown, John P., Ettl, Johannes, Schmidt, Marcus, Bondarenko, Igor M., Lang, Istvan, Pinter, Tamas, Boer, Katalin, Patel, Ravindranath, Randolph, Sophia, Kim, Sindy T., Huang, Xin, Schnell, Patrick, Nadanaciva, Sashi, Bartlett, Cynthia Huang, Slamon, Dennis J.
Published in Breast Cancer Res (2016)

Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab versus chemotherapy plus rituximab for relapsed/refractory aggressive B-cell non-Hodgkin lymphoma

by Dang, Nam H., Ogura, Michinori, Castaigne, Sylvie, Fayad, Luis E., Jerkeman, Mats, Radford, John, Pezzutto, Antonio, Bondarenko, Igor, Stewart, Douglas A., Shnaidman, Michael, Sullivan, Sharon, Vandendries, Erik, Tobinai, Kensei, Ramchandren, Radhakrishnan, Hamlin, Paul A., Giné, Eva, Ando, Kiyoshi
Published in Br J Haematol (2017)

Long-term functional health status and exercise test variables for patients with pulmonary atresia with intact ventricular septum: A Congenital Heart Surgeons Society study

by Karamlou, Tara, Poynter, Jeffrey A., Walters, Henry L., Rhodes, Jonathan, Bondarenko, Igor, Pasquali, Sara K., Fuller, Stephanie M., Lambert, Linda M., Blackstone, Eugene H., Jacobs, Marshall L., Duncan, Kim, Caldarone, Christopher A., Williams, William G., McCrindle, Brian W.
Published 2013

PF-05280014 (a trastuzumab biosimilar) plus paclitaxel compared with reference trastuzumab plus paclitaxel for HER2-positive metastatic breast cancer: a randomised, double-blind st...

by Pegram, Mark D., Bondarenko, Igor, Zorzetto, Marina Moreira Costa, Hingmire, Sachin, Iwase, Hirotaka, Krivorotko, Petr V., Lee, Keun Seok, Li, Rubi K., Pikiel, Joanna, Aggarwal, Rajesh, Ewesuedo, Reginald, Freyman, Amy, Li, Ray, Vana, Alicia, Yin, Donghua, Zacharchuk, Charles, Tan-Chiu, Elizabeth
Published in Br J Cancer (2018)